Cargando…
Targeting angiogenesis in Duchenne muscular dystrophy
Duchenne muscular dystrophy (DMD) represents one of the most devastating types of muscular dystrophies which affect boys already at early childhood. Despite the fact that the primary cause of the disease, namely the lack of functional dystrophin is known already for more than 30 years, DMD still rem...
Autores principales: | Podkalicka, Paulina, Mucha, Olga, Dulak, Jozef, Loboda, Agnieszka |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6439152/ https://www.ncbi.nlm.nih.gov/pubmed/30770952 http://dx.doi.org/10.1007/s00018-019-03006-7 |
Ejemplares similares
-
Simvastatin does not alleviate muscle pathology in a mouse model of Duchenne muscular dystrophy
por: Mucha, Olga, et al.
Publicado: (2021) -
Dysregulated Autophagy and Mitophagy in a Mouse Model of Duchenne Muscular Dystrophy Remain Unchanged Following Heme Oxygenase-1 Knockout
por: Mucha, Olga, et al.
Publicado: (2021) -
Muscle and cardiac therapeutic strategies for Duchenne muscular dystrophy: past, present, and future
por: Łoboda, Agnieszka, et al.
Publicado: (2020) -
miR-378 affects metabolic disturbances in the mdx model of Duchenne muscular dystrophy
por: Podkalicka, Paulina, et al.
Publicado: (2022) -
Age-Dependent Dysregulation of Muscle Vasculature and Blood Flow Recovery after Hindlimb Ischemia in the mdx Model of Duchenne Muscular Dystrophy
por: Podkalicka, Paulina, et al.
Publicado: (2021)